GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » Total Liabilities

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Total Liabilities : ¥852 Mil (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co Total Liabilities?

China Resources Boya Bio-pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥852 Mil.

China Resources Boya Bio-pharmaceutical Group Co's quarterly Total Liabilities increased from Sep. 2024 (¥575.96 Mil) to Dec. 2024 (¥913.38 Mil) but then declined from Dec. 2024 (¥913.38 Mil) to Mar. 2025 (¥852.02 Mil).

China Resources Boya Bio-pharmaceutical Group Co's annual Total Liabilities declined from Dec. 2022 (¥748.35 Mil) to Dec. 2023 (¥508.08 Mil) but then increased from Dec. 2023 (¥508.08 Mil) to Dec. 2024 (¥913.38 Mil).

China Resources Boya Bio-pharmaceutical Group Co Total Liabilities Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co Total Liabilities Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 974.93 701.30 748.35 508.08 913.38

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 520.26 538.09 575.96 913.38 852.02

China Resources Boya Bio-pharmaceutical Group Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

China Resources Boya Bio-pharmaceutical Group Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=750.376+(7.175+155.831
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=913

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=8401.145-7487.763
=913

China Resources Boya Bio-pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=696.576+(6.468+148.978
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=852

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=8478.707-7626.684
=852

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Boya Bio-pharmaceutical Group Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Boya Bio-pharmaceutical Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » Total Liabilities
Comparable Companies
SZSE:300009 SHSE:688382 SZSE:002287 SHSE:600866 SHSE:688068 SHSE:688076 SZSE:000403 SHSE:688520 SHSE:688739 SHSE:600645 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000
Website
https://www.china-boya.com
China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.
Executives
Liang Xiao Ming Directors, executives
Li Shou Sun Executives
Zhang Shi Fang Executives
Tu Yan Shi Directors, executives
Chen Bing Executives
Liao Xin Xi Directors, executives
Fan Yi Qin Secretary, Director
Jiang Guo Liang Supervisors
Xu Jian Xin Director
Duan Hong Zhuan Executives
Chen Hai Yan Executives
Hong Da Cheng Director

China Resources Boya Bio-pharmaceutical Group Co Headlines

No Headlines